WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Laura S. Duncan
Associate
Corporate
Seattle
lduncan@wsgr.com

D206-883-2578

Download vCard
Open PDF

Laura Duncan is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she works with private and public companies at all stages of growth, in addition to representing venture capital firms in private company financings and investment banks in public offerings. Laura's practice focuses on corporate and securities law, including general corporate representation, public offerings, venture capital financings, and mergers and acquisitions. She also counsels public companies on public disclosures and compliance with SEC and exchange rules.

Prior to joining the firm, Laura was an associate in the Washington, D.C., office of Sullivan & Cromwell LLP, where she represented major Latin American and U.S. companies and underwriters in connection with securities offerings and advised financial services clients on regulatory matters.

Laura is a native English and Portuguese speaker.

Experience

Laura Duncan is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she works with private and public companies at all stages of growth, in addition to representing venture capital firms in private company financings and investment banks in public offerings. Laura's practice focuses on corporate and securities law, including general corporate representation, public offerings, venture capital financings, and mergers and acquisitions. She also counsels public companies on public disclosures and compliance with SEC and exchange rules.

Prior to joining the firm, Laura was an associate in the Washington, D.C., office of Sullivan & Cromwell LLP, where she represented major Latin American and U.S. companies and underwriters in connection with securities offerings and advised financial services clients on regulatory matters.

Laura is a native English and Portuguese speaker.

Education
  • J.D., The George Washington University Law School, 2014
  • LL.B., Universidade Federal do Rio Grande do Sul, 2011
Admissions
  • Bar of the District of Columbia
  • State Bar of New York
  • State Bar of Washington
Credentials
Education
  • J.D., The George Washington University Law School, 2014
  • LL.B., Universidade Federal do Rio Grande do Sul, 2011
Admissions
  • Bar of the District of Columbia
  • State Bar of New York
  • State Bar of Washington
Focus Areas
  • Capital Markets
  • Corporate
  • Corporate Governance
  • Emerging Companies and Venture Capital
  • Mergers & Acquisitions
Recent Insights
Client Highlights
Wilson Sonsini Advises Micron on $1 Billion Senior Notes Offering
On January 16, 2025, Micron Technology, Inc., settled its offering of $1 billion aggregate principal amount of 5.80 percent senior notes due 2035. Micron intends to use the net proceeds from the sale of the notes to pay the redemption price of its outstanding 4.975 percent senior notes due 2026 and for general corporate purposes. Wilson Sonsini Goodrich & Rosati advised Micron on the transaction.

The Wilson Sonsini team representing Micron includes:
Learn More
Client Highlights
Wilson Sonsini Advises Zymeworks on Exclusive Licensing Agreement with Jazz Pharmaceuticals
On October 19 2022, Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Ltd. announced that they entered into an exclusive license agreement to develop and commercialize zanidatamab. Under that arrangement, Jazz will receive an exclusive license from Zymeworks to develop and commercialize zanidatamab in the United States, Europe, Japan, and all other territories except for those Asia/Pacific territories that Zymeworks previously licensed to BeiGene, Ltd. 
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.